RHYTHM PHARMACEUTICALS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2023-11-08: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2023-08-01: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2023-05-02: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2023-03-01: Form 10-K; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2023-11-08 | 10-Q | Smaller reporting company | Yes |
| 2023-08-01 | 10-Q | Smaller reporting company | Yes |
| 2023-05-02 | 10-Q | Smaller reporting company | Yes |
| 2023-03-01 | 10-K | Smaller reporting company | Yes |
| 2022-03-01 | 10-K | Well-known seasoned issuer | No |
| 2020-11-02 | 10-Q | Smaller reporting company | Yes |
| 2020-11-02 | 10-Q | Emerging growth company | Yes |
| 2020-08-03 | 10-Q | Stock registered under Section 12(b) | Common Stock · RYTM · NASDAQ |
| 2020-08-03 | 10-Q | Smaller reporting company | Yes |
| 2020-08-03 | 10-Q | Emerging growth company | Yes |
| 2020-05-04 | 10-Q | Smaller reporting company | Yes |
| 2020-05-04 | 10-Q | Emerging growth company | Yes |
| 2020-03-02 | 10-K | Emerging growth company | Yes |
| 2019-11-01 | 10-Q | Emerging growth company | Yes |
| 2019-07-29 | 10-Q | Emerging growth company | Yes |
| 2019-05-03 | 10-Q | Emerging growth company | Yes |
| 2019-03-08 | 10-K | Emerging growth company | Yes |
| 2018-11-09 | 10-Q | Emerging growth company | Yes |
| 2018-03-12 | 10-K | Well-known seasoned issuer | No |
| 2017-11-14 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |